Identification of resistance mutations to DAA's against Hepatitis C Virus in infected subjects in Mexico
Introduction and Objectives: Death due to liver damage caused by hepatitis C virus (HCV), this agent represents one of the most frequent health threats in Mexico. Now direct-acting antiviral agents (DAA's) are available to treat HCV infections. Nevertheless, HCV has gained mutations that hinder...
Main Authors: | K López-Riojas, KA Galán-Huerta, AF Ruiz-Higareda, L Muñoz-Espinosa, P Cordero-Pérez, D Arellanos-Soto, S Lozano-Sepúlveda, AM Rivas-Estilla |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2022-12-01
|
Series: | Annals of Hepatology |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1665268122001910 |
Similar Items
-
Complete genome sequence of Hepatitis C Virus isolated in Mexico
by: K López-Riojas, et al.
Published: (2022-12-01) -
Where is the focus on hepatitis C research after the introduction of DAAs: To Understand, knowledge, prevent or cure hepatitis C?
by: Ana M. Rivas-Estilla, et al.
Published: (2020-03-01) -
SARS-CoV-2 in Mexico: Beyond Detection Methods, Scope and Limitations
by: Cynthia Martinez-Liu, et al.
Published: (2021-01-01) -
Prevalence of SARS-CoV-2 Variants of Concern and Variants of Interest in COVID-19 Breakthrough Infections in a Hospital in Monterrey, Mexico
by: Kame A. Galán-Huerta, et al.
Published: (2022-01-01) -
Decline in influenza cases in Mexico after the implementation of public health measures for COVID-19
by: Daniel Arellanos-Soto, et al.
Published: (2021-05-01)